Direct nose-to-brain transfer of morphine after nasal administration to rats

被引:62
作者
Westin, UE
Boström, E
Gråsjö, J
Hammarlund-Udenaes, M
Björk, E
机构
[1] Uppsala Univ, Dept Pharm, SE-75123 Uppsala, Sweden
[2] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden
关键词
brain uptake; morphine; nasal drug delivery; nose-brain transport; olfactory pathway; rats;
D O I
10.1007/s11095-006-9534-z
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The aim of this study was to quantify the olfactory transfer of morphine to the brain hemispheres by comparing brain tissue and plasma morphine levels after nasal administration with those after intravenous administration. Methods. Morphine (1.0 mg/kg body weight) was administered via the right nostril or intravenously as a 15-min constant-rate infusion to male rats. The content of morphine and its metabolite morphine-3-glucuronide in samples of the olfactory bulbs, brain hemispheres, and plasma was assessed using high-performance liquid chromatography, and the areas under the concentration-time curves (AUC) were calculated. Results. At both 5 and 15 min after administration, brain hemisphere morphine concentrations after nasal administration were similar to those after i.v. administration of the same dose, despite lower plasma concentrations after nasal administration. The brain hemispheres/plasma morphine AUC ratios for the 0-5 min period were thus approximately 3 and 0.1 after nasal and i.v. administration, respectively, demonstrating a statistically significant early distribution advantage of morphine to the brain hemispheres via the nasal route. Conclusion. Morphine is transferred via olfactory pathways to the brain hemispheres, and drug transfer via this route significantly contributes to the early high brain concentrations after nasal administration to rats.
引用
收藏
页码:565 / 572
页数:8
相关论文
共 45 条
[1]   Novel routes of opioid administration [J].
Alexander-Williams, JM ;
Rowbotham, DJ .
BRITISH JOURNAL OF ANAESTHESIA, 1998, 81 (01) :3-7
[2]   Biovector™ nanoparticles improve antinociceptive efficacy of nasal morphine [J].
Betbeder, D ;
Sperandio, S ;
Latapie, JP ;
de Nadai, J ;
Etienne, A ;
Zajac, JM ;
Frances, B .
PHARMACEUTICAL RESEARCH, 2000, 17 (06) :743-748
[3]  
BEVINGTON PR, 1992, DATA REDUCTION ERROR, P45
[4]  
Bickel U, 1996, J PHARMACOL EXP THER, V278, P107
[5]  
BOURGET P, 1995, INT J CLIN PHARM TH, V33, P588
[6]   Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats -: A microdialysis study [J].
Bouw, MR ;
Gårdmark, M ;
Hammarlund-Udenaes, M .
PHARMACEUTICAL RESEARCH, 2000, 17 (10) :1220-1227
[7]  
Chen Xue-Qing, 1998, J Alzheimers Dis, V1, P35
[8]   Direct nose-brain transport of benzoylecgonine following intranasal administration in rats [J].
Chow, HHS ;
Anavy, N ;
Villalobos, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (11) :1729-1735
[9]  
Chow HHS, 1999, J PHARM SCI, V88, P754
[10]   Peak plasma concentrations after oral morphine: A systematic review [J].
Collins, SL ;
Faura, CC ;
Moore, RA ;
McQuay, HJ .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1998, 16 (06) :388-402